Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma.
about
Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodelerLiquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived BiomarkersThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateChromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast CancerHelical Repeat Structure of Apoptosis Inhibitor 5 Reveals Protein-Protein Interaction ModulesGenetic alterations in hepatocellular carcinoma: An updateTransgenic CHD1L expression in mouse induces spontaneous tumors.CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancerThe chromatin remodeling factor Chd1l is required in the preimplantation embryo.CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival.Chromodomain helicase/ATPase DNA binding protein 1-like protein expression predicts poor prognosis in nasopharyngeal carcinoma.CHD1L Regulated PARP1-Driven Pluripotency and Chromatin Remodeling During the Early-Stage Cell ReprogrammingThe interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancerApi5 contributes to E2F1 control of the G1/S cell cycle phase transition.Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma.Overexpression of N-terminal kinase like gene promotes tumorigenicity of hepatocellular carcinoma by regulating cell cycle progression and cell motility.Activation of the SNF2 family ATPase ALC1 by poly(ADP-ribose) in a stable ALC1·PARP1·nucleosome intermediate.Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors.Modulation of farnesoid X receptor results in post-translational modification of poly (ADP-ribose) polymerase 1 in the liver.Tripartite Motif-containing 33 (TRIM33) protein functions in the poly(ADP-ribose) polymerase (PARP)-dependent DNA damage response through interaction with Amplified in Liver Cancer 1 (ALC1) protein.An overview of hepatocellular carcinoma study by omics-based methods.Identification of CHD1L as an Important Regulator for Spermatogonial Stem Cell Survival and Self-Renewal.Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma.CHD1L: a novel oncogene.Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.Snf2-family proteins: chromatin remodellers for any occasion.Reprogramming cellular events by poly(ADP-ribose)-binding proteinsSystemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma.Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B.NOXIN as a cofactor of DNA polymerase-primase complex could promote hepatocellular carcinoma.CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection.Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p.Overexpression of CDC28 protein kinase regulatory subunit 1B confers an independent prognostic factor in nasopharyngeal carcinoma.Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma.Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1.Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.
P2860
Q24321560-1B497CE1-1654-4826-85DA-C1013F2A1731Q24655668-600771CF-0CBA-496B-A9B7-CC2E236FC8B4Q26741204-BC46FBE8-3EE2-4D35-B729-488219E6AF42Q27003050-3DE86C81-FC65-4D9C-8715-FDF9F7EBB8B8Q27342714-DE32EA34-3819-42C4-BDF7-D85FBE425CAAQ27677281-BF4D762B-AC81-49F5-9B92-F9D2205213B9Q28073241-318EF67A-32D4-4108-83D7-DCFEAF07643EQ33496125-67F7FAC6-4144-4FEF-A4BD-F7ACE9E568B5Q33755370-943A64D9-599F-4DC9-9D95-2B92EA63DCA7Q34083417-853927F3-F4F6-4F20-9094-E5CD3845D427Q34328978-E8AC1B01-6701-4993-B49F-BB9A46765796Q34424030-C590A3E7-83FD-4F2D-9859-FA320D3CBBC9Q34443999-8CEAD649-64C3-4F4E-91A7-96C8C23503F0Q34486397-ED2AB980-1B14-4620-81BE-93C669C6E04FQ34771536-E39AA90B-EA1E-4AEC-9CE2-4080CD73991DQ34937648-06A2BE37-1A5E-42A5-8B3D-A103E1203EFBQ35169398-13C09B97-80FE-46BB-8DC7-E419573F666EQ35176391-EE526D15-F15E-4F59-9EF6-909D2EA5BC96Q36481781-4E464B87-81E4-4706-814E-819D3138D4EAQ36544520-5E044B1B-9BDB-4038-8514-D177B9BE399EQ36574137-BF05AC3B-8C28-468E-BA46-16CE61BCF881Q36611566-981DB1B0-BEF8-457E-B5FB-17F6B6CCC469Q37174451-692904FD-2433-4930-AD0B-976AE2EB9062Q37289213-B7CD7A49-3410-485A-BAAB-D179E6A28A3CQ37364456-7FCE1AA7-F5D0-45EC-A7B5-13AFEE15A350Q37492628-04A0098B-A926-4620-9FE8-9AE4DBBF43EDQ37561673-0F01DE61-2905-4FE5-B14A-B5E0F7325F5AQ37597560-A5EE2D9B-20AE-449E-8CE8-7862CED39E76Q37777019-A607F498-2878-4F79-815E-1348E05ACC93Q37921466-B32648C6-652F-49CD-BFB5-C14F419F9E7DQ38069879-E212AEB1-6BCF-4ACC-9E3D-695F59B6A275Q39629883-F0A3CC52-C479-430D-A260-05CCDC5FCE17Q39764810-20952C3D-2CE4-4879-B4CB-F7091B6A4353Q41542420-40B664C2-6153-4949-9335-8377854F8FAAQ41550872-720EB5D6-6DCA-4174-BBA9-8F5A89DAED16Q41947839-DDA6E8BF-7F6D-4CBC-B891-1742A731679BQ44416846-236A6A52-6882-4597-9710-F04C61611834Q47098880-BFBEE903-6D56-4D9B-9CAA-DAACF0B2940DQ47126896-15380EBE-F2D5-4AFD-8C0B-E2A78B3A5D03Q47745588-E0EC5C54-BB7C-4F7F-9BBC-E50CA701A976
P2860
Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Isolation and characterization ...... 1 in hepatocellular carcinoma.
@en
type
label
Isolation and characterization ...... 1 in hepatocellular carcinoma.
@en
prefLabel
Isolation and characterization ...... 1 in hepatocellular carcinoma.
@en
P2093
P50
P356
P1433
P1476
Isolation and characterization ...... 21 in hepatocellular carcinoma
@en
P2093
Bo-Jian Zheng
Dong-Jiang Tang
Jackie M Fung
Leilei Chen
Muhan Chen
Ning-Fang Ma
P2860
P304
P356
10.1002/HEP.22072
P407
P577
2008-02-01T00:00:00Z